Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice

Neuroscience

Volumn 223, Issue , 2012, Pages 246-257

  Rojas, P ^a   Ruiz Sanchez E ^a   Rojas, C ^b   Ogren S O ^c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

EGb 761; Gene expression; MPTP; Nurr1; Parkinson's disease model

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GINKGO BILOBA EXTRACT; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; SODIUM CHLORIDE; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DA-D2R GENE; DAT GENE; DOPAMINERGIC NERVE CELL; GENE; GENE EXPRESSION REGULATION; MALE; MESENCEPHALON; MOUSE; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NURR1 GENE; PARKINSONISM; PITX3 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TH GENE; TRANSCRIPTION REGULATION; UPREGULATION; VMAT2 GENE;

ANIMALS; ANTIPARKINSON AGENTS; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; MALE; MICE; MICE, INBRED C57BL; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PARKINSONIAN DISORDERS; PLANT EXTRACTS; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84865813909     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.08.004     Document Type: Article

References (75)

1. Augustin S., Rimbach G., Augustin K., Cermak R., Wolffram S. Gene regulatory effects of Ginkgo biloba extract and its flavonol and terpenelactone fractions in mouse brain. J Clin Biochem Nutr 2009, 45:315-321.
2. Araki T., Mikami T., Tanji H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur J Pharm Sci 2001, 12:231-238.
3. Anderson D.W., Bradbury K.A., Schneider J.S. Neuroprotection in Parkinson models varies with toxin administration protocol. Eur J Neurosci 2006, 24:3174-3182.
4. Antony P.M.A., Diederich N.J., Balling R. Parkinson's disease mouse models in translational research. Mamm Genome 2011, 22:401-419.
5. Blesa J, Phani S, Jackson-Lewis V, Przedborski S (2012) Classic and new animal models of Parkinson's disease. J Biomed Biotechnol. http://dx.doi.org/10.1155/2012/845618.
6. Bonci A., Hopf F.W. The dopamine D2 receptor: new surprises from an old friend. Neuron 2005, 47:335-338.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
8. Chung S., Sonntag K.C., Anderson T., Bjorklund L.M., Park J.J., Kim D.M. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 2002, 16:1829-1838.
9. Costa-Mallen P., Costa L.G., Smith-Weller T., Franklin G.M., Swanson P.D., Checkoway H. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatr 2000, 69:535-537.
10. DeFeudis F.V. Ginkgo biloba extract (EGb 761): From chemistry to the clinic 1998, Wiesbaden, Germany, Ullstein Medical, pp. 7-42.
11. DeFeudis F.V., Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000, 1:25-58.
12. DeFeudis F.V. Effects of Ginkgo biloba extract (EGb 761) on gene expression: possible relevance to neurological disorders and age-associated cognitive impairment. Drug Dev Res 2002, 57:214-235.
13. DeKosky S.T., Fitzpatrick A., Ives D.G., Saxton J., Williamson J., Lopez O.L., Burke G., Fried L., Kuller L.H., Robbins J., Tracy R., Woolard N., Dunn L., Kronmal R., Nahin R., Furberg C. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contem Clin Trials 2006, 27:238-253.
14. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11:1475-1489.
15. Drieu K. Preparation and definition of Ginkgo biloba extract. Presse Med 1986, 15:1455-1457.
16. Droy-Lefaix M.T., Cluzel J., Menerath J.M., Bonhomme B., Doly M. Antioxidant effect of a Ginkgo biloba extract (EGb 761) on the retina. Int J Tissue React 1995, 17:93-100.
17. Ferger B., Spratt C., Teismann P., Seitz G., Kuschinsky K. Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo. Eur J Pharmacol 1998, 360:155-163.
18. Frey K.A., Koeppe R.A., Kilbourn M.R. Imaging the vesicular monoamine transporter. Adv Neurol 2001, 86:237-247.
19. Gibrat C., Saint-Pierre M., Bousquet M., Lévesque D., Rouillard C., Cicchetti F. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem 2009, 109:1469-1482.
20. Glatt C.E., Wahner A.D., White D.J., Ruiz-Linares A., Ritz B. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008, 312:131-138.
21. Gohil K., Packer L. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell Mol Biol (Noisy-le-grand) 2002, 48:625-631.
22. Guidetti C., Paracchini S., Lucchini S., Cambieri M., Marzatico F. Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol 2001, 53:387-392.
23. Goridis C., Rohrer H. Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci 2002, 3:531-541.
24. Harrington K.A., Augood S.J., Kingsbury A.E., Foster O.J., Emson P.C. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Brain Res Mol Brain Res 1996, 36:157-162.
25. Herrschaft H., Nacu A., Likhachev S., Sholomov I., Hoerr R., Schlaefke S. Ginkgo biloba extract EGb 761(®) in dementia with neuropsychiatric features: a randomised, placebo- controlled trial to confirm the efficacy and safety of a daily dose of 240mg. J Psychiatr Res 2012, 46:716-723.
26. Jankovic J., Chen S., Le W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol 2005, 77:128-138.
27. Jenner P. Clues to the mechanism underlying dopamine cell death in Parkinson's disease. J Neurol Neurosurgery Psychiatr 1989, (Suppl.):22-28.
28. Jourdain S., Morissette M., Morin N., Di Paolo T. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol 2005, 17:509-517.
29. Kingston R.E., Chomczynski P., Sacchi N. Preparation and analysis of RNA. Current protocols in molecular biology 1996, 421-429. New York, Wiley. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl (Eds.).
30. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
31. Le W., Conneely O.M., He Y., Jankovic J., Appel S.H. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem 1999, 73:2218-2221.
32. Le W.D., Xu P., Jankovic J., Jiang H., Appel S.H., Smith R.G., Vassilatis D.K. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 2003, 33:85-89.
33. Lee G.S., Cho J.H., Park C.S., Jung S.H., Lee D.H., Jun B.C., Song C.E., Cho K.J. The effect of Ginkgo biloba on the expression of intermediate-early antigen (c-fos) in the experimentally induced anosmic mouse. Auris Nasus Larynx 2009, 36:287-291.
34. Li J., Dani J.A., Le W. The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease. Curr Top Med Chem 2009, 9:855-859.
35. Liu H., Wei L., Tao Q., deng H., Ming M., Xu P., Le W. Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease. Eur J Neurol 2012, 19:870-875.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001, 25:402-408.
37. Mahdy H.M., Tadros M.G., Mohamed M.R., Karim A.M., Khalifa A.E. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. Neurochem Int 2011, 59:770-778.
38. Maitra I., Marcocci L., Droy-Lefaix M.T., Packer L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 1995, 49:1649-1655.
39. Martinat C., Bacci J.J., Leete T., Kim J., Vanti W.B., Newman A.H., Cha J.H., Gether U., Wang H., Abeliovich A. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 2006, 103:2874-2879.
40. Messmer K., Remington M.P., Skidmore F., Fishman P.S. Induction of tyrosine hydroxylase expression by the transcription factor Pitx3. Int J Dev Neurosci 2007, 25:29-37.
41. Miller R.M., Callahan L.M., Casaceli C., Chen L., Kiser G.L., Chui B., Kaysser-Kranich T.M., Sendera T.J., Palaniappan C., Federoff H.J. Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci 2004, 24:7445-7454.
42. Mohanakumar K.P., Muralikrishnan D., Thomas B. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Brain Res 2000, 864:281-290.
43. Nagatsu T., Sawada M. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm 2007, 72:113-120.
44. Ni Y., Zhao B., Hou J., Xin W. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 1996, 214:115-118.
45. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 2003, 100:4245-4250.
46. Ojeda V., Fuentealba J.A., Galleguillos D., Andrés M.A. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. J Neurosc Res 2003, 73:686-697.
47. Owen A.D., Schapira A.H.V., Jenner P., Marsden C.D. Oxidative stress and Parkinson's disease. Ann NY Acad Sci 1996, 786:217-223.
48. Panzacchi A., Moresco R.M., Garibotto V., Antonini A., Gobbo C., Isaias I.U., Goldwurm S., Bonaldi L., Carpinelli A., Pezzoli G., Fazio F., Perani D. A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset. Neurobiol Dis 2008, 31:102-109.
49. Park S.W., Kim S.H., Park K.H., Kim S.D., Kim J.Y., Baek S.Y., Chung B.S., Kang C.D. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease. Neurosci Lett 2004, 363:243-246.
50. Pohjalainen T., Rinne J.O., Någren K., Lehikoinen P., Anttila K., Syvälahti E.K., Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Psychiatry 1998, 3:256-260.
51. Przedborski S., Jackson-Lewis V., Djaldetti R., Liberatore G., Vila M., Vukosavic S., Almer G. The Parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 2000, 16:135-142.
52. Rinne J.O., Laihinen A., Lönnberg P., Marjamäki P., Rinne U.K. A post-mortem study on striatal dopamine receptors in Parkinson's disease. Brain Res 1991, 556:117-122.
53. Ritz B.R., Manthripragada A.D., Costello S., Lincoln S.J., Farrer M.J., Cockburn M., Bronstein J. Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect 2009, 117:964-969.
54. Rojas P., Rojas C., Ebadi M., Montes S., Monroy-Noyola A., Serrano-García N. EGb 761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochem Res 2004, 29:1417-1423.
55. Rojas P., Serrano-García N., Mares-Sámano J.J., Medina-Campos O.N., Pedraza-Chaverri J., Ogren S.O. EGb 761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Role of oxidative stress. Eur J Neurosci 2008, 28:41-50.
56. Rojas P, Montes P, Rojas C, Serrano-García N, Rojas-Castañeda J (2012). Effect of a phytopharmaceutical medicine, EGb 761, in an animal model of Parkinson's disease: therapeutic perspectives. Nutrition. doi:10.1016/j.nut.2012.03.007.
57. Sala G., Brighina L., Saracchi E., Fermi S., Riva C., Carrozza V., Pirovano M., Ferrarese C. Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease. J Neural Transm 2010, 117:1093-1098.
58. Singh M., Khan A.J., Shah P.P., Shukla R., Khanna V.K., Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008, 312:131-138.
59. Singer T.P., Castagnoli N Jr., Ramsay RR., Trevor AJ. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 1987, 49:1-8.
60. Smidt M.P., van Schaick H.S., Lanctôt C., Tremblay J.J., Cox J.J., van der Kleij A.A., Wolterink G., Drouin J., Burbach J.P. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci USA 1997, 94:13305-13310.
61. Smidt M.P., Burbach J.P. How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 2007, 8:21-32.
62. Smith J.V., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 2004, 64:465-472.
63. Soulié C., Nicole A., Christen Y., Ceballos-Picot I. The Ginkgo biloba extract EGb 761 increases viability of hnt human neurons in culture and affects the expression of genes implicated in the stress response. Cell Mol Biol (Noisy-le-grand) 2002, 48:641-646.
64. Speciale S.G. MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol Teratol 2002, 24:607-620.
65. Sriram K., Pai K.S., Boyd M.R., Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res 1997, 749:44-52.
66. Su S.Y., Hsieh C.L., Wu S.L., Cheng W.Y., Li C.C., Lo H.Y., Ho T.Y., Hsiang C.Y. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo. J Ethnopharmacol 2009, 123:68-73.
67. Tatton N.A., Kish S.J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 1997, 77:1037-1048.
68. von Boetticher A. Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatr Dis Treat 2011, 7:441-447.
69. Watanabe C.M., Wolffram S., Ader P., Rimbach G., Packer L., Maguire J.J., Schultz P.G., Gohil K. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci USA 2001, 98:6577-6580.
70. Wu W.R., Zhu X.Z. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999, 65:157-164.
71. Wong S.S., Li R.H., Stadlin A. Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes. Brain Res 1999, 836:237-244.
72. Xu Z., Cawthon D., McCastlain K.A., Slikker W., Ali S.F. Selective alterations of gene expression in mice induced by MPTP. Synapse 2005, 55:45-51.
73. Xu P.Y., Liang R., Jankovic J., Hunter C., Zeng Y.X., Ashizawa T., Lai D., Le W.D. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 2002, 58:881-884.
74. Yeh K.Y., Wu C.H., Tai M.Y., Tsai Y.F. Ginkgo biloba extract enhances noncontact erection in rats: the role of dopamine in the paraventricular nucleus and the mesolimbic system. Neuroscience 2011, 189:199-206.
75. Yoshitake T., Yoshitake S., Kehr J. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 2010, 159:659-668.